Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses. - van Ravensteijn SG; de Haan JJ; Gelderblom H; Nederkoorn MJL; Hillebrandt-Roeffen MHS; Gorris MAJ; de Bitter TJJ; Boleij A; Gusinac A; Ederveen THA; Flucke UE; Bonenkamp JJ; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)